GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Probiotix Health PLC (AQSE:PBX) » Definitions » Research & Development

Probiotix Health (AQSE:PBX) Research & Development : £0.00 Mil (TTM As of Jun. 2023)


View and export this data going back to 2022. Start your Free Trial

What is Probiotix Health Research & Development?

Research & Development is the aggregate amount of research and development expenses during the year. Probiotix Health's Research & Development for the six months ended in Jun. 2023 was £0.00 Mil. Its Research & Development for the trailing twelve months (TTM) ended in Jun. 2023 was £0.00 Mil.

Probiotix Health Research & Development Historical Data

The historical data trend for Probiotix Health's Research & Development can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Probiotix Health Research & Development Chart

Probiotix Health Annual Data
Trend Dec18 Dec19 Dec20 Dec22
Research & Development
- 0.17 - -

Probiotix Health Semi-Annual Data
Dec18 Dec19 Jun20 Dec20 Jun21 Jun22 Dec22 Jun23
Research & Development Get a 7-Day Free Trial - - - - -

Probiotix Health Research & Development Calculation

This is the expense the company spent on research and development.

Research & Development for the trailing twelve months (TTM) ended in Jun. 2023 adds up the semi-annually data reported by the company within the most recent 12 months, which was £0.00 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Probiotix Health  (AQSE:PBX) Research & Development Explanation

If competitive advantage is created by a patent or tech advantage, at some point it will disappear.

High R&D usually dictates high SG&A which threatens the competitive advantage.

Probiotix Health Research & Development Related Terms

Thank you for viewing the detailed overview of Probiotix Health's Research & Development provided by GuruFocus.com. Please click on the following links to see related term pages.

Probiotix Health (AQSE:PBX) Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Probiotix Health PLC (AQSE:PBX) » Definitions » Research & Development
Comparable Companies
LSE:ROQ LSE:BSFA LSE:IMM LSE:OCTP LSE:CIZ LSE:IXI LSE:BVX LSE:APTA LSE:EVG AQSE:INC OCSE:NOVO B VRTX REGN ASX:CSL SGEN XKRX:207940 MRNA XBRU:ARGX HKSE:02269 BNTX
Traded in Other Exchanges
X90:Germany
Address
Nostell Business Estate, First Floor Zucchi Suite, Wakefield, GBR, WF4 1AB
Website
https://www.probiotixhealth-ir.com
Probiotix Health PLC develops probiotics to tackle cardiovascular disease and other lifestyle conditions which are affecting growing numbers of people across the world. The Company has one class of business, in three geographical areas being that of identifying and developing microbial strains, compounds and formulations for use in the nutraceutical industry.

Probiotix Health (AQSE:PBX) Headlines

No Headlines